Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Basal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05550766
What this trial is testing

Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

Who this might be right for
Non-melanoma Skin Cancer
Sohag University 50
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00002963
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01835626
What this trial is testing

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell CarcinomaSkin CancerCutaneous Malignancy
Sue Yom 24
Not applicableActive Not RecruitingNCT06608511
What this trial is testing

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Who this might be right for
Skin CancerMelanoma (Skin Cancer)Basal Cell Carcinoma of Skin+3 more
University of Wisconsin, Madison 20
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Not applicableApproved For MarketingNCT06132191
What this trial is testing

Expanded Access Use of Cemiplimab in Patients With Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Basal Cell Carcinoma (BCC)Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT04389112
What this trial is testing

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinomas
University Hospital, Bordeaux 119
Early research (Phase 1)Active Not RecruitingNCT04616248
What this trial is testing

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more
University of Southern California 14
Early research (Phase 1)Looking for participantsNCT07600476
What this trial is testing

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaMucosal MelanomaCutaneous Squamous Cell Carcinoma (CSCC)+2 more
Kupando GmbH 21
Very early researchLooking for participantsNCT07286318
What this trial is testing

Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more
Marissa Lobl 20
Not applicableUnknownNCT03742726
What this trial is testing

Study Assessing the Safety and Performance of Smart Matrix®

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Smart Matrix Limited 32
Testing effectiveness (Phase 2)Looking for participantsNCT07251413
What this trial is testing

Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma

Who this might be right for
Cutaneous Basal Cell Carcinoma
Instituto Oncológico Dr Rosell 18
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT03889912
What this trial is testing

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 97
Not applicableActive Not RecruitingNCT03737734
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Next Page